iRhythm Holdings (IRTC) FCF Margin (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly FCF Margin came in at 16.73% in Q2 2026, up 747.0% year-over-year from 1.98% in Q2 2025, and up 200.88% quarter-over-quarter from 16.59% in Q1 2026.
Analysis
iRhythm Holdings (IRTC) FCF Margin (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported FCF Margin for 12 consecutive years, with 16.73% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin rose 747.0% year-over-year to 16.73% in Q2 2026; TTM through Jun 2026 was 4.72%, a 48.0% increase from a year earlier, with the FY2025 full-year figure at 4.62%, up 978.0% from the prior year.
- FCF Margin was 16.73% for Q2 2026 at iRhythm Holdings, up from 16.59% in the prior quarter.
- Over five years, FCF Margin peaked at 16.73% in Q2 2026 and troughed at 48.13% in Q1 2022.
- A 5-year average of 7.92% and a median of 4.45% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin slumped 2712 bps in 2023 and soared 3594 bps in 2025, its largest moves.
- Over 5 years, FCF Margin stood at 4.87% in 2022, then tumbled by 557 bps to 22.25% in 2023, then jumped by 134 bps to 7.54% in 2024, then decreased by 8 bps to 6.94% in 2025, then soared by 141 bps to 16.73% in 2026.
- The last three FCF Margin figures came in at 16.73% (Q2 2026), 16.59% (Q1 2026), and 6.94% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.07 Bn | 45.97 Bn | 486.15 Mn | -1.15% |
| 2 | Labcorp Holdings | 26.22 Bn | 26.08 Bn | 1.11 Bn | 8.41% |
| 3 | Quest Diagnostics | 25.95 Bn | 25.32 Bn | 1.03 Bn | 15.08% |
| 4 | Guardant Health | 21.86 Bn | 20.80 Bn | 219.03 Mn | -20.76% |
| 5 | Tempus AI | 11.23 Bn | 10.41 Bn | 274.25 Mn | -3.57% |
| 6 | Caris Life Sciences | 6.95 Bn | 6.16 Bn | 182.38 Mn | 2.43% |
| 7 | Sotera Health | 5.25 Bn | 4.89 Bn | 177.96 Mn | 13.08% |
| 8 | BillionToOne | 4.71 Bn | 4.16 Bn | 77.11 Mn | 4.65% |
| 9 | iRhythm Holdings | 4.00 Bn | 3.41 Bn | 163.21 Mn | 16.73% |
| 10 | Adaptive Biotechnologies | 3.90 Bn | 3.56 Bn | 51.39 Mn | -10.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.73% |
| Mar 31, 2026 | -16.59% |
| Dec 31, 2025 | 6.94% |
| Sep 30, 2025 | 10.40% |
| Jun 30, 2025 | 9.26% |
| Mar 31, 2025 | -10.91% |
| Dec 31, 2024 | 7.54% |
| Sep 30, 2024 | 10.51% |
| Jun 30, 2024 | 2.26% |
| Mar 31, 2024 | -46.85% |
| Dec 31, 2023 | -22.25% |
| Sep 30, 2023 | -6.33% |
| Jun 30, 2023 | -11.25% |
| Mar 31, 2023 | -35.16% |
| Dec 31, 2022 | 4.87% |
| Sep 30, 2022 | -2.56% |
| Jun 30, 2022 | -10.98% |
| Mar 31, 2022 | -48.13% |
| Dec 31, 2021 | -21.60% |
| Sep 30, 2021 | 5.11% |